Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
LSE:AZN
AstraZeneca PLC
|
121.10 | 18,89% | 41,61% | 187.733,46 | 2,01% | 15,98% |
|
NYSE:ABT
Abbott Laboratories
|
104.09 | 2,43% | 15,17% | 181.078,48 | 2,1% | 9,04% |
|
NYSE:PFE
Pfizer
|
28.64 | 8,42% | 38,65% | 162.291,22 | 5,81% | -9,31% |
|
TSE:4502
Takeda Pharmaceutical Company
|
4130.00 | 0% | 0% | 6.479.696,8 | 4,74% | 0% |
|
ENXTBR:ARGX
argenx
|
339.90 | 0% | 0% | 20.200,62 | 0% | 0% |
|
CPSE:GMAB
Genmab A/S
|
2041.00 | 64,8% | 124,4% | 131.830,48 | 0% | 22,71% |
|
NasdaqGS:VTRS
Viatris Inc
|
10.98 | 5,13% | 15,66% | 13.324,53 | 4,36% | -8,55% |
|
ENXTPA:IPN
Ipsen
|
120.80 | -14,58% | -6,56% | 9.878,9 | 0,99% | 9,14% |
|
NasdaqGS:CHDN
Churchill Downs
|
133.62 | 90,46% | 139,03% | 10.173,08 | 0,28% | 22,35% |
|
CPSE:ZEAL
Zealand Pharma A/S
|
600.00 | 0% | 0% | 38.517,01 | 0% | 0% |
|
LSE:HIK
Hikma Pharmaceuticals PLC
|
19.78 | 25,31% | 38,17% | 4.424,39 | 2,87% | 10,04% |
|
HLSE:ORNBV
Orion Oyj
|
37.69 | 22,61% | 65,62% | 5.117,58 | 4,3% | -0,43% |
|
CPSE:ALK B
ALK-Abelló A/S
|
152.00 | 48,16% | 94,21% | 33.908,31 | 0% | 171,44% |
|
NasdaqGS:ALRM
Alarm.com Holdings
|
69.04 | -1,68% | 9,05% | 3.452,48 | 0% | 9,25% |
|
ENXTPA:VIRP
Virbac
|
354.50 | 25,12% | 39,72% | 2.979,62 | 0,37% | 43,8% |
|
XTRA:MOR
MorphoSys
|
69.35 | 0% | 0% | 2.523,4 | 0% | 0% |
|
NasdaqCM:CORT
Corcept Therapeutics
|
28.09 | -34,78% | -10,92% | 2.552,83 | 0% | 2,03% |
|
NYSE:BHC
Bausch Health Companies
|
6.77 | 146,24% | 169% | 2.549,24 | 0% | -2,74% |
|
LSE:INDV
Indivior PLC
|
13.37 | -23,61% | -1,68% | 1.952,43 | 0% | -2,7% |
|
NasdaqGS:PENN
PENN Entertainment
|
15.93 | -91,57% | 22,71% | 2.287,35 | 0% | -42,92% |
